KEWALRAMANI RESHMA (CEO & President) purchased 9.4% of their position (10K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market purchase worth $3.90M — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/7/2025ACC: 0000875320-25-000220
DirectorOfficer· CEO & President
Since Feb 2026
+10K
Net shares
Net buyer
$3.90M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
10K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.29K
Price / share
$389.08
Trade value
$1.67M
% of position
4.0%
8/6/2025
105.97K→110.26K
Common Stock
Direct
Shares
+5.71K
Price / share
$389.95
Trade value
$2.23M
% of position
5.2%
8/6/2025
110.26K→115.97K
Total
Net shares
+10K
Net value
$3.90M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/6/2025 | P · Purchase | +4.29K | $389.08 | $1.67M | 4.0% | 105.97K | 110.26K |
| Common Stock Direct | 8/6/2025 | P · Purchase | +5.71K | $389.95 | $2.23M | 5.2% | 110.26K | 115.97K |
| Total | +10K | $3.90M | ||||||
Derivative Transactions0
No derivative transactions reported